Form of granulomatous uveitis occurring in the region of the pars plana. This disorder is a common condition with no detectable focal pathology. It causes fibrovascular proliferation at the inferior ora serrata.
Inflammation in which both the anterior and posterior segments of the uvea are involved and a specific focus is not apparent. It is often severe and extensive and a serious threat to vision. Causes include systemic diseases such as tuberculosis, sarcoidosis, and syphilis, as well as malignancies. The intermediate segment of the eye is not involved.

Results of peripheral laser photocoagulation in pars planitis. (1/8)

PURPOSE: To determine the effect of peripheral retinal laser photocoagulation (PLP) on visual acuity, intraocular inflammation, and other ocular findings, including retinal neovascularization in eyes with pars planitis. METHODS: A retrospective chart review of eyes with pars planitis that had undergone PLP. RESULTS: Twenty-two eyes in 17 patients with pars planitis had undergone treatment with PLP at 2 centers. The mean age at the time of treatment was 19.3 years. Following treatment, mean follow-up was 16.3 months (range, 6 to 37 months). Mean visual acuity was 20/60 preoperatively and 20/50 postoperatively. This level of improvement was not statistically significant (P > .10), but there was a statistically significant decrease in the use of corticosteroids between the preoperative examination and the last postoperative examination (86% versus 27%, P < .05). There was also a statistically significant decrease in vitritis at the last follow-up (P = .0008) and a decrease in neovascularization of the vitreous base (P = .03) and in clinically apparent cystoid macular edema (P = .02). Epiretinal membranes were noted in 23% of eyes preoperatively and in 45% of eyes postoperatively. Only one of these epiretinal membranes was considered to be visually significant. One eye developed a tonic dilated pupil, which slowly improved. CONCLUSIONS: Although the long-term natural history of clinical findings in pars planitis is not well documented, PLP appears to decrease the need for corticosteroids while stabilizing visual acuity. It also appears to decrease vitreous inflammation. PLP has few complications and should be considered in patients with pars planitis who are unresponsive or have adverse reactions to corticosteroids.  (+info)

Characterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in man. (2/8)

Intermediate uveitis (IU) and Fuchs' heterochromic cyclitis (FHC) are two chronic ocular inflammatory disorders. They differ considerably in ocular morbidity, which is higher in IU. T cell lines were derived from the vitreous humour (VH) and peripheral blood (PB) of 10 patients with IU and four patients with FHC. There was a predominance of CD8+ in all the lines. However, there was a significantly higher percentage of CD4+ T cells in the T cell lines derived from VH of IU (32.0 +/- 8.6%) compared with FHC patients (19. 2 +/- 8.9%) (P = 0.04). The VH-derived T cell lines (VDTC) produced significantly higher levels of IL-2, interferon-gamma (IFN-gamma) and IL-10, but not IL-4, compared with PB-derived T cell lines (PBDTC) in both entities. There was significantly higher IL-2 production by VDTC from IU when compared with FHC patients (1810 +/- 220 pg/ml versus 518 +/- 94 pg/ml; P = 0.009), which could account for the more aggressive clinical features of this condition. In contrast IL-10 production was significantly higher by the VDTC from FHC compared with IU patients. The high IL-10 production by T cells infiltrating VH of FHC patients could down-regulate the inflammatory responses, thereby contributing to the benign clinical course seen in these patients. The accumulation of T cells with differing cytokine profiles in the VH suggests an important role for these cytokines in the pathogenesis of these chronic uveitides.  (+info)

High levels of IgG class antibodies to recombinant HSP60 kDa of Yersinia enterocolitica in sera of patients with uveitis. (3/8)

AIMS: To determine the levels of IgG class antibodies to recombinant heat shock protein 60 kDa of Yersinia enterocolitica (rHSP60Ye), Klebsiella pneumoniae (rHSP60Kp), Escherichia coli (rHSP60Ec), Shigella flexneri (rHSP60Sf), and Streptococcus pyogenes (rHSP60Sp) in the serum of patients with HLA-B27 associated acute anterior uveitis (HLA-B27 associated AAU), idiopathic acute anterior uveitis (idiopathic AAU), pars planitis, Vogt-Koyanagi-Harada (VKH), and healthy subjects. METHODS: The genes that code for HSP60Ye, HSP60Kp, HSP60Ec, HSP60Sf, and HSP60Sp were cloned by PCR from genomic DNA. The rHSPs were purified by affinity using a Ni-NTA resin. The serum levels of IgG class antibodies to rHSP60s were determined by ELISA in patients with uveitis (n = 42) and in healthy subjects (n = 25). RESULTS: The majority of patients with uveitis had higher levels of IgG class antibodies to rHSP60Ye compared with levels of healthy subjects (p = 0.01), although these differences were only observed in the HLA-B27 associated AAU (p = 0.005) and in pars planitis patients (p = 0.001). The levels of IgG antibodies to the rHSP60Kp, rHSP60Sf, rHSP60Ec, and rHSP60Sp were similar in patients with uveitis and in healthy subjects (p>0.05). CONCLUSION: The results suggest that HSP60Ye could be involved in the aetiology of HLA-B27 associated AAU and pars planitis.  (+info)

Pars planitis is associated with an increased frequency of effector-memory CD57+ T cells. (4/8)

AIM: To evaluate the frequency, phenotype and the potential function of CD57+ T cell subsets in patients with pars planitis. METHODS: CD4+CD57+ and CD8+CD57+ T cells were quantitated in peripheral blood from 15 patients with pars planitis and 15 healthy controls. To evaluate the phenotype and potential function of CD57+ T cell subsets CCR7, CD27, CD28, CD45RA, CD45RO, intracellular IFN-gamma, IL-4, perforin and granzyme-A expression were assessed by flow cytometry. RESULTS: CD57+ T cells subsets were increased in patients with pars planitis (p = 0.002). The majority of CD4+CD57+ T cells were CCR7-CD27-CD28-CD45RO+, while the most CD8+CD57+ T cells were CCR7-CD27-CD28-CD45RA+. The number of cells positive for intracellular IFN-gamma and IL-4 was higher in the CD57+ T cell populations. A greater number of CD8+CD57+ T cells than CD8+CD57- T cells were positive to perforin (p = 0.006) and granzyme-A (p = 0.01). CONCLUSIONS: CD57+ T cells had a phenotype associated with peripheral memory (CCR7-CD27-CD28-). Cytokine production by CD57+ T cells suggests that these cells may play a role in helper cell regulation. High expression of intracellular proteins involved in cytotoxicity suggests that CD8+CD57+ T cells may play an effector role. Taken together, this study proposes that CD57+ T cells function as memory-effector T cell subsets during pars planitis pathogenesis.  (+info)

Pars plana vitrectomy and internal limiting membrane peeling for macular oedema secondary to retinal vein occlusion: a pilot study. (5/8)

INTRODUCTION: Macular oedema is the main cause of visual impairment following retinal vein occlusion. The purpose of this study was to evaluate the anatomical and functional outcome of pars plana vitrectomy and internal limited membrane (ILM) peeling for macular oedema secondary to retinal vein occlusion. CLINICAL PICTURE: This pilot study is a prospective nonrandomised series of 11 eyes of 11 patients with macular oedema secondary to retinal vein occlusion. The best-corrected visual acuity (BCVA), foveal thickness on optical coherence tomography, fundus fluorescein angiography (FFA) and multifocal electroretinography were evaluated. TREATMENT AND OUTCOME: All 11 patients underwent pars plana vitrectomy with ILM peeling. The mean postoperative follow-up was 13.5 months (range, 1.5 to 24). The mean thickness at the foveal centre decreased from 794 +/- 276 microm preoperatively to 373 +/- 150 microm, 302 +/- 119 microm, 249 +/- 203 microm and 185 +/- 66 microm at 1 week, 1 month, 3 months and the final visit postoperatively, respectively (all P <0.001, paired t- test, compared to preoperative thickness). Postoperative FFA demonstrated markedly reduced leakage in the macular region. At the final visit, BCVA improved 2 lines or more in 72.7% (8/11) of patients and was unchanged in 27.3% (3/11) patients. Complications included cataract in 7 patients and vitreous haemorrhage, recurrence of macular oedema and visual field defect in 1 case each. CONCLUSION: Pars plana vitrectomy and ILM peeling rapidly reduced the macular oedema caused by retinal vein occlusion, with improvement in BCVA.  (+info)

Identification, quantitation, and purification of a 36 kDa circulating protein associated with active pars planitis. (6/8)

PURPOSE: To establish a correlation between the presence of a 36 kDa protein in the blood of patients with pars planitis and to characterize and purify this protein. METHODS: Blood samples were obtained from patients with pars planitis and other types of uveitis and from various controls. Samples were treated with polyethelene glycol and protein A and were analyzed on 10% SDS-PAGE for the presence of a 36 kDa protein. Quantitative estimation of the level of this protein was determined by densitometric tracing of the stained gels. Polyclonal antibodies were raised by immunizing New Zealand White rabbits with a mixture of the gel fragment containing the 36 kDa protein (p-36) and complete Freund's adjuvant. These antibodies were used in the immunoaffinity purification of this protein. RESULTS: The levels of p-36 were sixfold to eightfold higher in 81% of the patients with active pars planitis than in controls (P < 0.05). Furthermore, the levels of this protein correlated with disease activity. A partial amino terminal sequence analysis revealed that p-36 may be a novel protein. It has been purified from the patient's blood using affinity chromatography. CONCLUSIONS: A 36 kDa protein (p-36) is found in elevated concentrations in the blood of many patients with active pars planitis. Its putative role in the etiopathogenesis of pars planitis is unknown.  (+info)

Molecular cloning, sequencing, and expression of the 36 kDa protein present in pars planitis. Sequence homology with yeast nucleopore complex protein. (7/8)

PURPOSE: Patients with active pars planitis have increased levels of a 36 kDa protein (p-36) in their circulation. The current studies were undertaken to determine the primary structure of this protein. METHODS: A degenerate oligonucleotide probe based on the amino terminal sequence of p-36 was used to identify a clone from a human spleen cDNA library. The cDNA insert was subcloned into the EcoR1 site of pUC-19, and both strands were sequenced. Southern blot analysis was used to study the genomic hybridization pattern. p-36 cDNA was subcloned in a pSG5 expression vector, and the construct was used to transfect COS-7 cells. RESULTS: The cDNA sequence contained an open reading frame of 966 base pairs encoding a protein of 322 amino acids, an untranslated region of 322 base pairs, and 2693 base pairs at the 5' and 3' ends, respectively. The deduced amino acid sequence showed 96.8% identity with the carboxy-terminal region of a yeast nucleopore complex protein, nup 100. Southern blot analysis of human genomic DNA revealed a simple hybridization pattern. Transfection of p-36 cDNA in COS-7 cells resulted in the presence of p-36 mRNA and expression of protein. CONCLUSIONS: The 36 kDa protein (p-36) detected at increased levels in the blood of patients with active pars planitis was cloned from a human spleen cDNA library. Its deduced amino acid sequence is homologous with the carboxy-terminal region of a nucleopore complex protein. Thus, we refer to this protein as nup36.  (+info)

Ultrasound biomicroscopic imaging in intermediate uveitis. (8/8)

BACKGROUND: Clinical examination of the region of the eye mainly affected in patients with intermediate uveitis is difficult and often hampered by media opacities. In that perspective ultrasound biomicroscopy (UBM) promises to be a valuable additional diagnostic tool. METHODS: UBM was performed at a sound frequency of 50 MHz on 26 eyes of 13 patients with intermediate uveitis in order to determine configuration of pars plana, peripheral retina, and vitreous. Findings of ophthalmoscopy with scleral indentation and UBM were compared. RESULTS: In 18 of 26 eyes pathological structures such as membraneous or fluffy vitreous condensations were identified by UBM. Among these UBM revealed pathological findings which were not visible on funduscopy in nine eyes. Most importantly, vitreoretinal adhesions with traction on the retina were imaged in four eyes. However, in three eyes vitreous opacities being visible on funduscopy were not identified by UBM. CONCLUSION: UBM seems to be a valuable diagnostic technique for the evaluation of patients with intermediate uveitis. Longitudinal studies will have to determine the relevance of UBM findings for the individual clinical course and their influence on therapeutic decisions.  (+info)

Pars planitis is not a formally recognized medical condition according to the latest classification system for uveitis (inflammation of the eye), proposed by the International Uveitis Study Group in 2019. However, historically, pars planitis was used to describe a form of intermediate uveitis where there is a specific inflammatory process involving the pars plana, a region of the eye between the ciliary body and the retina. It is often characterized by the presence of "snowball" or "string of pearls" opacities in the vitreous humor (the gel-like substance that fills the space between the lens and the retina).

The new classification system for uveitis has replaced the term pars planitis with "intermediate uveitis associated with snowbank/snowball opacity." This change acknowledges that inflammation in this region can be part of a broader spectrum of intermediate uveitis, which may involve other parts of the eye as well.

It is essential to consult a medical professional or an ophthalmologist for accurate information and treatment options related to any eye condition.

Panuveitis is a medical term that refers to inflammation that affects the entire uveal tract, including the iris, ciliary body, and choroid. The uveal tract is the middle layer of the eye between the inner retina and the outer fibrous tunic (sclera). Panuveitis can also affect other parts of the eye, such as the vitreous, retina, and optic nerve.

The symptoms of panuveitis may include redness, pain, light sensitivity, blurred vision, floaters, and decreased visual acuity. The condition can be caused by various factors, including infections, autoimmune diseases, trauma, or unknown causes (idiopathic). Treatment typically involves the use of corticosteroids to reduce inflammation, as well as addressing any underlying cause if identified. If left untreated, panuveitis can lead to complications such as cataracts, glaucoma, and retinal damage, which can result in permanent vision loss.

Uveitis Pars Planitis... anyone else have this too?. Ive had this diagnosis since I was 15 (now 24), and I have never met or ...
Connect people with Pars Planitis close to you and help each other. , Diseasemaps ...
Another form of uveitis is pars planitis. Inflammation occurs in the area called the pars plana, which is located between the ... Pars planitis most often occurs in young men. It is generally not associated with any other disease. However, it may be linked ... Pars planitis is often treated with steroid eye drops. Other medicines, including steroids taken by mouth, may be used to help ... If you are over age 25 and have pars planitis, your provider will suggest a brain and spine MRI. This will rule out multiple ...
Khodadoust AA, Karnama Y, Stoessel KM, Puklin JE (November 1986). "Pars planitis and autoimmune endotheliopathy". American ...
Other terms used in the literature include chronic cyclitis, peripheral uveitis, and pars planitis. The term pars planitis is ... Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis. Ophthalmology. 1999 Jun. ... However, Dev et al reported favorable visual results in a group of patients with pars planitis. [13] The investigators also ... Cataract extraction and IOL placement is probably safe in patients with Fuchs heterochromic iridocyclitis, pars planitis, acute ...
Pars Planitis. *Pigment Dispersion Syndrome. *Pinguecula. *Pinkeye (Conjunctivitis). *Presbyopia. *Progressive High Myopia ...
... and pars plana. Pars planitis should be used only for that subset of intermediate uveitis where there is snowbank or snowball ... Peripheral retinitis may be seen in pars planitis, multiple sclerosis, sarcoidosis, punctate outer toxoplasmosis, or ARN. ... and pars planitis occur most frequently in young adults. Reactive arthritis (also referred to as Reiter syndrome), ankylosing ... but they do not appear in pars planitis. Chronic anterior uveitis also frequently develops posterior synechiae, with or without ...
Wendy Smith discusses intermediate uveitis, including pars planitis. Resident Lecture * 0 * 45 ...
Pars Planitis * Presbyopia * Pseudoexfoliation Glaucoma * Pseudophakia * Pseudotumor Cerebri * Pterygium * Punctal Stenosis * ...
Pars Planitis * Presbyopia * Pseudoexfoliation Glaucoma * Pseudophakia * Pseudotumor Cerebri * Pterygium * Punctal Stenosis * ...
Pars Planitis...299 • Bests Disease...300 • Posterior Polar Cataract...301 • Pseudotumor Cerebri...302 • Congenital Motor ...
Pars planitis uveitis in sarcoidosis, SLE *GI upset. *Bone marrow toxicity (leucopenia, thrombocytopenia) ...
Schwaller shares her experience of living with pars planitis, a form of uveitis. ...
Inflammation primarily affecting the vitreous is referred to as "intermediate uveitis", and includes pars planitis, posterior ... Multiple sclerosis, sarcoidosis and other diseases in patients with pars planitis. Dev Ophthalmol. 1992;23:41-47. ... 43 and several authors have noted an association between pars planitis and multiple sclerosis (MS), although this has yet to be ... pars planitis, sympathetic ophthalmia, idiopathic uveitis, Crohns disease, and HLA-B27-positive disease, a positive response ...
Intermediate uveitis (pars planitis). *Posterior uveitis. *Panuveitis (inflammation throughout the eye). Why choose us for ...
70 80 00 Pars planitis 70 81 00 Pars planitis, active 70 82 00 Pars planitis, inactive 70 83 00 Pars planitis, granulomatous 70 ... 70 85 00 Pars planitis, inactive, granulomatous 70 86 00 Pars planitis, nongranulomatous 70 87 00 Pars planitis, active, ... 70 88 00 Pars planitis, inactive, nongranulomatous 70 9. .. Panuveitis----See Inflammation, uveal, other 70 90 00 Inflammation ...
Pars Planitis. *Persistent Fetal Vasculature. *Presumed Ocular Histoplasmosis Syndrome. *Retained Lens Fragments ...
... pars planitis, sarcoidosis, or Behçets disease. Finally, one must consider neoplastic causes such as primary intraocular ...
Pars planitis: a 20-year study of incidence, clinical features and outcomes. Am J Ophthalmol. 2007;144(6):812-7. ... Ozdal PC, Berker N, Tugal-Tutkun I. Pars planitis: epidemiology, clinical characteristics, management and visual prognosis. J ... The specialist was able to discuss with the patient and his mother the possible benefit of pars plana vitrectomy and membrane ...
Of this group, keratitis, vitreitis, and pars planitis are the most common. The keratitis usually is a bilateral, patchy, ... Posterior segment inflammatory disease generally presents as a bilateral pars planitis associated with granulomatous iritis and ...
Pars Planitis. 84. DR1. VKH. 16. †Negative-predictive value 99%.. VKH: Vogt-Koyanagi-Harada.. Data taken from [52]. ...
Pars planitis From NCATS Genetic and Rare Diseases Information Center. * [Clinical and epidemiological features and HLA ... Genetic polymorphism of HLA DR in a Scottish population of patients with pars planitis. Greiner KH, et al. European journal of ... association in patients with pars planitis]. Mantrana-Bermejo María Eugenia, et al. Medicina clínica 2010 7 (5) 205-8 ...
Pars planitis. Joint involvement. Bone cysts. Calcium metabolism. Hypercalcaemia. Urolithiasis. Cardiac. Cardiomyopathy. ...
Pars Planitis Asthma Goodpastures Disease Pemphigus Vulgaris Atopic Allergy Graves Disease Polyglandular Autoimmune Syndromes ...
Pars Planitis Asthma Goodpastures Disease Pemphigus Vulgaris Atopic Allergy Graves Disease Polyglandular Autoimmune Syndromes ...
Pars planitis. *Personage turner syndrome. *Pemphigus. *Peripheral neuropathy. *Perivenous encephalomyelitis. *Pernicious ...
There are several types, defined by the part of the eye involved: iritis (front part of the eye), pars planitis (middle part of ...
Pars Planitis Market: https://www.growthplusreports.com/report/pars-planitis-market/8373 ...
  • Another form of uveitis is pars planitis. (medlineplus.gov)
  • Ms. Schwaller shares her experience of living with pars planitis, a form of uveitis. (preventblindness.org)
  • Inflammation primarily affecting the vitreous is referred to as "intermediate uveitis", and includes pars planitis, posterior cyclitis, and hyalitis. (dovepress.com)
  • There are several types, defined by the part of the eye involved: iritis (front part of the eye), pars planitis (middle part of the eye), posterior uveitis (back part of the eye), and panuveitis (front and back of the eye). (ceenta.com)
  • Intermediate Uveitis includes Pars Planitis and Cyclitis. (imatrix.com)
  • These diseases include scleritis, iritis, pars planitis and posterior uveitis-all conditions commonly associated with rheumatologic disorders and systemic infections. (ehnpc.com)
  • Diseases such as pars planitis and uveitis can cause the formation of clumps of white blood cells (cells that the body produces when there is inflammation). (shroffeye.org)
  • intermediate uveitis, also known as pars planitis, consists of vitritis-which is inflammation of cells in the vitreous cavity, sometimes with snowbanking, or deposition of inflammatory material on the pars plana. (medicaltourismindia.net.in)
  • Inflammation occurs in the area called the pars plana, which is located between the iris and the choroid. (medlineplus.gov)
  • This inflammation affects the area (pars plana) where the retina inserts into the iris and ciliary body. (imatrix.com)
  • METHODS: Five patients with malignant glaucoma and a long-term absence of the anterior chamber underwent a combination of anterior pars plana vitrectomy (aPPV), phacoemulsification cataract excision, intraocular lens implantation, peripheral iridotomy (PI), goniosynechialysis (GSL) (referred to aPPV + P + I + PI + GSL) at Beijing Tongren Hospital from October 2018 to June 2021. (bvsalud.org)
  • Pars planitis is often treated with steroid eye drops. (medlineplus.gov)
  • Pars planitis is often treated with topical steroids, but may require periocular or system steroids. (imatrix.com)
  • Pars planitis most often occurs in young men. (medlineplus.gov)
  • Pars planitis usually occurs in young men and is generally not associated with any other disease. (imatrix.com)
  • If you are over age 25 and have pars planitis, your provider will suggest a brain and spine MRI. (medlineplus.gov)
  • Persons over age 25 with Pars Planitis should have an MRI of their brain and spine to rule out the association with multiple sclerosis. (imatrix.com)
  • Inflammatory and connective tissue causes must be considered, such as sympathetic ophthalmia (especially given this patient's history of trauma to the fellow eye), pars planitis, sarcoidosis, or Behçet's disease. (ophthalmologytimes.com)
  • 16. A comparison of visual results and complications in eyes with posterior chamber intraocular lens dislocation treated with pars plana vitrectomy and lens repositioning or lens exchange. (nih.gov)
  • We describe a case report of pediatric pars planitis complicated with massive exudative retinal detachment (ERD). (bvsalud.org)
  • 5. Pars plana vitrectomy for vitreous opacity associated with ocular sarcoidosis resistant to medical treatment. (nih.gov)
  • 14. Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis. (nih.gov)
  • Dehghan M.H., Mashayekhi A., XX1st meeting of the club Jules Gonin 28 august- 1september 1998, Edinburgh - Scotland 3 - Outcomes of surgical (pars plicata and limbal lensectomy, vitrectomy) and non-surgical management of persistent hyperplastic primary vitreous (PHPV). (drugstorepdfsearch.com)
  • Mashayekhi A., Ahamdieh H., soheilian M.,Azarmina M., Dehghan M.H. 5th Iranian congress of ophthalmology Thran IR iran 1995 9 - Primary capsulectomy and anterior vitrectomy combined with lensectomy and PCIOL implantation in children: limbal VS pars plana approach. (drugstorepdfsearch.com)
  • Produce proliferación fibrovascular en la ora serrata inferior. (bvsalud.org)
  • The objectives of the present study were to describe the clinical and epidemiological features of patients with pars planitis diagnosed in our hospital as well as the prevalence of multiple sclerosis and HLA class I and II. (nih.gov)
  • There appears to be no association between the occurrence of pars planitis and HLA DR 15 or other known HLA genotypes in Spanish patients. (nih.gov)
  • Epidemiological studies on North American patients reported an association between HLA DR15 and pars planitis. (nih.gov)
  • No statistical association was found between pars planitis and HLA. (nih.gov)
  • Acute zonal occult outer retinopathy (AZOOR) and pars planitis: A new association? (elsevierpure.com)
  • In one case report, a patient with cat scratch disease presented with pars planitis. (medscape.com)
  • We report a challenging total ERD as a complication of pars planitis. (bvsalud.org)

No images available that match "pars planitis"